Amylyx Pharmaceuticals Inc (NAS:AMLX)
$ 19.73 +0.18 (+0.95%) Market Cap: 2.19 Bil Enterprise Value: 1.92 Bil PE Ratio: 0 PB Ratio: 8.02 GF Score: 33/100

Amylyx Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript

May 13, 2026 / 08:40 PM GMT
Release Date Price: $14.58 (+0.97%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AMLX.OQ - Amylyx Pharmaceuticals Inc
Amylyx Pharmaceuticals Inc at Bank of America Global Healthcare Conference
May 13, 2026 / 08:40PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
This is the company presenter at the B of A Annual Healthcare Conference. My name is Jason Gerberry. I cover pharma and biotech, and I'm pleased to be introducing Amlex Pharmaceutical and Joshua Cohen, Co-Chief Executive Officer. And this is an interesting. Interesting time for Amlyx on the cusp of pivotal phase three data expected in the third quarter, a transformational event. So I imagine a lot of our discussion is going to be focused on the lead program for PBH. So Josh, thanks for joining us.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot